We detected significantly different values after three and six months when compared to the baseline parameters before treatment in NASH cohort for the following parameters: SUA, ALT, AST, GGT, calcium, magnesium, and HOMA-IR, as presented in Table 2. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.